🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Bioresorbable Magnesium Set Screws in Syndesmotic Injuries: a Pilot Study

Recruitingn/aAges 18 Years - 100 YearsAllPatrick Lukas Holweg, MD
NCT07901205 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary aim of this prospective single-center pilot study is to evaluate the implant function of the bioresorbable magnesium set screw (ZX00) for the surgical fixation of the syndesmosis in isolated syndesmotic injuries as well as in bi- and trimalleolar fractures after 12 weeks and 1 year postoperatively. Participants will be routinely operated due to a isolated syndesmotic injury at the department of orthopaedics and trauma. For study purposes patients were asked to complete three questionnaires (NRS, AOFAS, FAAM) at baseline visit, 2, 4, 6, 12 weeks and 12 months follow up. To assess implant integration and resorption kinetics, a CT scan will be performed after 12 weeks and after 1 year.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Minimum age 18 years * Isolated syndesmotic injury or bi-/trimalleolar fracture with syndesmotic injury * Consent to participate in the study Exclusion Criteria: * Inadequate trauma, diagnosed osteoporosis, or osteopenic bone structure * Polytrauma * Previous surgical treatment of the syndesmosis * Advanced post-traumatic osteoarthritis or pre-existing degenerative or inflammatory diseases of the ankle joint * Underlying conditions (morbid obesity, diabetes mellitus, peripheral vascular disease, fungal foot infection, peripheral neuropathy, rheumatic diseases, autoimmune diseases) * Systemic corticosteroid therapy for more than 3 months * Pregnancy and breastfeeding * Inability or unwillingness to provide informed consent
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Orthopaedics and Trauma, Medical University of Graz
Graz, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy